44th ESAO and 7th IFAO Congress Prefinal Program

as of 27-07-2017

September 6 -9, 2017 / Vienna, Austria

05.09.2017,Tuesday 12:30 18:00-

PC1 PreCongress Meeting: yESAO (I)

12:30 "The Grand Waltz of Artificial Organs"Spinning Circles Between Challenges and Solutions

20:00 yESAO Come Together

06.09.2017,Wednesday 09:00 12:00-

PC2 PreCongress Meeting: yESAO (II)

06.09.2017,Wednesday 09:00 12:00-

PC3 PreCongress Meeting: ICCAC/ESAO MCS Proficiency Course

separate ticket required

06.09.2017,Wednesday 12:00 13:00-

LU Lunch

06.09.2017,Wednesday 13:00 15:30-

PC4 PreCongress Meeting: yESAO (III)

06.09.2017,Wednesday 13:00 15:30-

PC5 PreCongress Meeting: ICCAC/ESAO MCS Proficiency Course

separate ticket required

06.09.2017,Wednesday 16:00 18:00-

OC Opening Ceremony

Bioinspired Engineering: From Human Organs-on-Chips to Dialysis-Like Therapeutic Devices

OL

D. Ingber; Boston, US

07.09.2017,Thursday 08:30 09:30-

A11 Symposium: Challenges in Development and Application of VADs (sponsored by Medtronic Inc.)

08:30 Intelligent Monitoring of Patients and their VADs

IL

F. Moscato; Vienna, AT

08:45 Challenges of minimal invasive implantsIL

D. Zimpfer; Vienna, AT

09:00 Current progress of VAD-implantation in Japan

IL

T. Nishimura; Tokyo, JP

09:15 Analytic reports from J-MACS: Focusing on the differences from the results of other VAD registries

IL

M. Ono; Tokyo, JP

07.09.2017,Thursday 08:30 09:30-

B11 Liver Failure

08:30 MARS efficiency according to treatment modalities: Experience in patients affected by acute-on-chronic liver failure (ACLF) and comparison with data reported in the literature

O

R. Marangoni; Como, IT

1

08:42 Molecular Adsorbent Recirculating System (MARS) in acute liver injury and graft dysfunction: Results from a case control study

O

H. Gerth; Muenster, DE

2

08:54 Effects of normothermic liver perfusion after 1 hour of warm ischemia

O

I. Fernandez-Lopez; Madrid, ES

3

09:06 Liver functionality model during normothermic perfusion

O

A. Rivera; Madrid, ES

4

07.09.2017,Thursday 08:30 09:30-

C11 Biomaterials I: Hard Tissue Replacement

08:30 Structure and properties of carbon fiber-reinforced hydroxyapatite composite matrix

O

N. Arkharova; Moscow, RU

5

08:40 Supramolecular gelatin nano-composites with enhanced sol-gel transition temperature

O

M. Mohseni Moghaddam; Tehran, IR

6

08:50 Experimental investigation and numerical analysis of the PMMA-based biocompatible vertebral cement flow

O

D. Obidowski; Lodz, PL

7

09:00 Transformation of Hydrogel Scaffolds using Ultrashort Laser Pulses for Tissue Engineering

O

M. Savelyev; Zelenograd, RU

8

09:10 Osteo-balls with Organic-Inorganic Chimeric Hydrogel Microbeads for Rapid Bone Formation

O

S. Iwanaga; Toyama, JP

9

09:20 Bone ingrowth in macro porous tricalcium phosphate implants produced by lithography-based ceramic manufacturing (LCM)

O

D. Bomze; Vienna, AT

10

07.09.2017,Thursday 08:30 09:30-

D11 Symposium: Limb Prostheses

08:30 Technical Design Considerations for Restauration of Prostheses based Movements

IL

W. Mayr; Vienna, AT

08:54 Development of a modular bionic prototype arm prosthesis

O

C. Kast; Vienna, AT

11

09:06 A Preliminary Test of Online Learning FES Control by Feedback Error Learning Using Fuzzy Controller in Controlling Knee Extension Movement

O

T. Watanabe; Sendai, JP

12

09:18 Development process of prosthetic device for upper limb

O

O. Canciglieri Junior; Curitiba, BR

13

07.09.2017,Thursday 09:30 10:30-

PL I Plenary Session I

09:30 The future of Mechanical Cardiac SupportPL

J. Long; Oklahoma City, US

1

10:00 Development of Complex Air-way Tissue Models and their Biomedical Applications

PL

H. Walles; Würzburg, DE

2

07.09.2017,Thursday 11:00 12:30-

A12 Heart & Pump: Modelling and Control

11:00 Venous physiology and cavopulmonary support in Fontan patients

O

M. Granegger; Zurich, CH

14

11:15 Exercise physiology with a VAD: study of left ventricular energetics with a computational model

O

L. Fresiello; Leuven, BE

15

11:30 In-Vitro Evaluation of Starling-like Control Based on Estimated Left Ventricular Stroke Work

O

E. Wu; Brisbane, AU

16

11:45 Stroke volume estimation and extreme membrane positions detection in pulsatile ventricular assist device.

O

A. Siewnicka; Warsaw, PL

17

12:00 Cardiac contractility index derived from pump flow during external rotary blood pump support: an in vitro study

O

P. Naiyanetr; Nakorn Pathom, TH

18

12:15 ECG-synchronized rotational speed change system has preventive effect on right heart failure during continuous-flow left ventricular assist device support.

O

D. Akiyama; Suita, Osaka, JP

19

07.09.2017,Thursday 11:00 12:30-

B12 Materials in Aphereses and Dialysis

11:00 Blood-Biomaterial Interactions in Extracorporeal Circulation.

O

A. Campbell Ritchie; Nottingham, GB

20

11:12 Mixed matrix membranes for outside-in dialysis

O

O. ter Beek; Enschede, NL

21

11:24 Mixed matrix membranes for the removal of endotoxins during hemodialysis

O

I. Geremia; Enschede, NL

22

11:36 Integrally skinned asymmetric cellulose acetate-silica membranes for extracorporeal blood ultrafiltration.

O

M. Faria; Lisbon, PT

23

11:48 Interpreting pore size values in membranes for renal replacement therapy

O

A. Boschetti-de-Fierro; Hechingen, DE

24

12:00 Biocompatible comparison in polysulfone membranes between polyvinylpyrrolidone and hydrophilic polymer coating for hemodialysis

O

K. Togo; Tokyo, JP

25

12:12 Assessment of blood trauma due to hematocrit variations in dialyzers

O

F. Mouzakis; Aachen, DE

26

07.09.2017,Thursday 11:00 12:30-

C12 Symposium: Tissue Regeneration (in cooperation withTERMIS)

11:00 Soft-biomimetic environments to support cell organization and function

IL

J. Mano; Aveira, PT

11:20 Biomimetic Materials for Cartilage Engineering

IL

M. Zenobi-Wong; Zuerich, CH

11:40 Engineering hydrogels to promote cell differentiation in soft tissue regeneration

IL

G. Gallego-Ferrer; Valencia, ES

12:00 Combining surface functionalized scaffolds with stem cells for advanced therapies

IL

N. Neves; Minho, PT

12:20 Discussion

07.09.2017,Thursday 11:00 12:30-

D12 Symposium: New Aspects of Albumin (Albunet)

11:00 The European ALBUNET network: Mission and Visions

O

J. Vienken; Usingen, DE

27

11:10 Analysis of albumin function by investigating conformational mobility

O

K. Schnurr; Berlin, DE

28

11:30 Non-invasive monitoring of bilirubin decrease in extracorporeal liver support patients

O

M. Preussiger; Wuppertal, DE

29

11:50 Extracorporeal liver support: Approaching the patient with liver failure

O

B. Tyczynski; Essen, DE

30

12:10 OPAL vs MARS:A case control study of two extracorporeal albumin dialysis techniques

O

C. Wilms; Münster, DE

31

07.09.2017,Thursday 12:30 14:00-

LS I Lunch with Corporate Member Symposium: Optimizing Hemocompatibility - Opportunity and Challenge for Developers

Peristaltik vs. Membran Pumps in Purification Techniques- What's New?

O. Favre; Geneva, CH

Optimizing hemocompatibility in VADs

A. Wisniewski; Berlin, DE

Access to clean water – core for dialysis

G. Grundström; Deerfield, US

07.09.2017,Thursday 14:00 15:30-

A13 Symposium: ICCAC-ESAO International VAD Coordinators

14:00 Blood pressure management in VAD patients: same limitations, new ideas?

IL

D. Robson; Sydney, AU

14:12 Why Did you Implant That Patient: The Vad Coordinator as Link between ICU and VAD Team

IL

H. Moody; Louisville, US

14:24 Vad Simulation for Staff Education- Practice Makes Perfect

IL

T. Elliott; Washington, US

14:36 Driveline Infections: Accept the challengeIL

P. Combs; Oak Lawn, US

14:48 Do LVAD patients need a specific diet to control weight ?

O

K. Vandersmissen; Leuven, BE

32

15:00 Dying on a device: Challenges in end-of-life care of VAD patients

IL

D. Roefe; Bad Oeynhausen, DE

15:12 Caring for the pediatric VAD patient - they aren't just small adults

IL

J. Lantz; Dallas, US

07.09.2017,Thursday 14:00 15:30-

B13 Symposium: Citrate Anticoagulation

14:00 Regional citrate anticoagulation in continuous renal replacement therapy

IL

T. Slowinski; Berlin, DE

14:20 Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients

IL

L. Kramer; Vienna, AT

14:40 Citrate, use and proof of the use in pediatric apheresis

IL

V. Witt; Vienna, AT

15:00 Influence of Citrate Concentration on Platelet Activation During Lipid Apheresis

O

R. Weiss; Krems, AT

33

15:15 Citrate Clearance of Current Dialysers: An In Vitro Study

O

J. Hartmann; Krems, AT

34

07.09.2017,Thursday 14:00 15:30-

C13 Tissue Engineering & Regenerative Medicine I

14:00 Preliminary clinical results of the bioartificial TraVaSc Implant for airway reconstruction

IL

T. Walles; Magdeburg, DE

14:20 3D-bioprinted capillary-like networks as versatile organ-on-a-chip platform

O

A. Blaeser; Aachen, DE

35

14:32 Tissue-engineered heart valve can change histological character after implantation

O

Y. Takewa; Osaka, JP

36

14:44 Reconstructing the blood vasculature within decellularized liver for generating a functional humanized organ

O

K. Hussein; Chuncheon, KR

37

14:56 Effect of porosity in freeze-dried decellularized porcine pulmonary heart valves on proteins and biomechanical properties

O

A. Vásquez-Rivera; Hannover, DE

38

15:08 Mid-term outcome of Cardiac Regenerative Therapy with Autologous Myoblast Cell Sheet Transplantation for Ischemic Cardiomyopathy

O

K. Domae; Suita, Osaka, JP

39

15:20 Discussion

07.09.2017,Thursday 14:00 15:30-

D13 Symposium: Cardiac Valves

14:00 Current topics and future perspectives of surgery for valve disease in Japan

IL

K. Toda; Osaka, JP

14:30 In vitro calcification and mechanical loading on heart valves: development of new and improved model of in vivo processes

O

D. Mavrilas; Patras, GR

40

14:40 Functional Mitral Regurgitation Model in an Ex-Vivo Platform.

O

M. Jaworek; Milano, IT

41

14:50 In-vivo evaluation of ConVes a novel device for a sutureless aortic graft anastomosis

O

S. Dual; Zürich, CH

42

15:00 Development of an innovative design for a large-size percutaneous pulmonary valve prosthesis

O

A. Gruenwald; Aachen, DE

43

15:10 Discussion

07.09.2017,Thursday 15:30 16:30-

PS1 Cardiac Assist Devices in Clinical Application I

Destination Therapy LVAD and Cancer: A case against Darwin’s Survival of the Fittest

P

L. Samuels; Philadelphia, US

1

Predictor for weaning from extracorporeal membrane oxygenation in infants with heart failure

P

T. Goto; HIrosaki, JP

2

The experience on technical supervision of patients supported by HVAD system

P

R. Kustosz; Zabrze, PL

3

Blood pressure control in heart failure patients supported by a centrifugal left ventricular assist device

P

N. Reiss; Bad Rothenfelde, DE

4

Effects of Ventricular Assist Device on cardiac troponin T isoform expression in pediatric patients with heart failure.

P

R. Ragusa; Pisa, IT

5

Outcomes of heart transplantation following support by MicroMed® DeBakey VAD® versus Heartware® HVAD® – A single center study.

P

P. Angleitner; Vienna, AT

6

Minimally invasive biventricular support with percutaneous extracorporeal membrane oxygenation and left ventricular assist system through mini-thoracotomy

P

K. Domae; Suita City, Osaka, JP

7

Mapping and ablation during mechanical circulatory support (BerlinHeart) in a child with diagnosed tachycardia-induced cardiomyopathy. Is this the way to wean?

P

J. Śliwka; Zabrze, PL

8

07.09.2017,Thursday 15:30 16:30-

PS2 Cardiac Assist Devices in Clinical Application II

Cardiac rehabilitation of left ventricular assist device patients requiring renal replacement therapy - a major challenge

P

N. Reiss; Bad Rothenfelde, DE

9

The Experience of using ECMO on an infant after Modified Nikaidoh Procedure.

P

Q. Wu; Beijing, CN

10

The usefulness of peripheral ECMO as a bridge to implantable LVAD in progressive decline heat failure patients

P

H. Hata; Suita, Osaka, JP

11

Clinical Course, Functional Capacity and Discontinuation of RVAD after Planned and Unplanned Biventricular Support System Implantation

P

N. Reiss; Bad Rothenfelde, DE

12

Short and long term left and right ventricular mechanics after LVAD implantation in pediatric patients: a 2D and 2Dspeckle tracking echocardiographic study

P

R. Iacobelli; Rome, IT

13

Do adults with a durable continuous-flow left ventricular assist device (LVAD) require an assigned caregiver on discharge?

P

D. Robson; Sydney, AU

14

International VAD Coordinator Practices: Clinical Utility and Application of HeartWare HVAD System Waveforms and Logfiles

P

T. Schlöglhofer; Vienna, AT

15

Development of a Suction Detection Algorithm from Patient Pump Data.

P

M. Maw; Vienna, AT

16

07.09.2017,Thursday 15:30 16:30-

PS3 Cardiac Assist Devices: Blood Trauma and Various Topics

The Evaluation of Hemolysis in a Ventricular Assist Device-Preliminary study

P

Y. Zhang; Beijing, CN

17

Blood damage by handling: The crux of the matter

P

L. Wiegmann; Zurich, CH

18

Influence of the thrombus formation on the heat generation in the Sputnik RBP: In vitro studies

P

A. Porfiryev; Moscow, RU

19

Regurgitant flow in mechanical heart valves: fluid stresses and spatial correlation

P

M. Grigioni; Rome, IT

20

Oxidative stress increases susceptibility of red blood cells to shear-mediated damage

P

A. McNamee; Gold Coast, AU

21

Haemodilution Increases the Fragility of Red Blood Cells in Response to Mechanical Stress

P

C. Robinson; Swansea, GB

22

Erythrocyte tolerance to supra-physiological shear stress with exposure times reflective of clinical blood pumps

P

J. Horobin; Gold Coast, AU

23

Inductive energy transfer for personalized artificial organs

P

A. Danilov; Moscow, RU

24

Efficiency Measurement of Air-Core Transcutaneous Energy Transmission Systems for Ventricular Assist Devices Considering Common-Mode Currents for a Transformer Immersed in a NaCl Solution at a Transmission Frequency of 500 kHz

P

T. Kaga; Katsushika, JP

25

Transcutaneous energy transmission by capacitive coupling

P

E. Drigo; Sao Paulo, BR

26

Transcutaneous Energy Transmission using Capacitive Coupling for Cardiac Pacemaker: Calculation of AC-AC Energy Transmission Efficiency

P

S. Kometani; Katsushika, JP

27

Experimental and Numerical Analysis of Dye Washout in Ventricular Assist Devices

P

A. Molteni; Swansea, GB

28

07.09.2017,Thursday 15:30 16:30-

PS4 Dialysis/Apheresis - Experimental Approaches

Mathematic model of blood glucose dynamics

P

K. Pozhar; Moscow, Zelenograd, RU

29

Study of the effect of module geometry on forward filtration in hollow fiber dialyzers with a two-dimensional momentum transport model

P

D. Donato; Hechingen, DE

30

Modeling water transport across the cell membrane in HD patients

P

M. Pietribiasi; Warsaw, PL

31

Modified p(HEMA) cryogels as potential cell carriers for liver tissue engineering

P

F. Bonalumi; Brighton, GB

32

Sieving coefficients of hemodialysis membranes

P

M. Hulko; Hechingen, DE

33

Possible influence of hemodialysis on oxidative stress

P

P. Dejanov; Skopje, MK

34

Treatment of thrombotic microangiopathy with therapeutic plasma exchange using citrate anticoagulation

P

B. Bizjak; Ljubljana, SI

35

Citrate anticoagulation: Influence of haematocrit on the extraction ratio of citrate and urea

P

K. Strobl; Kems, AT

36

Influence of different anticoagulants on endotoxin activity in human serum

P

S. Harm; Krems, AT

37

Lipoprotein-associated phospholipase A2 Predicts Cardiovascular outcomes in peritoneal dialysis patients

P

M. Li; Hangzhou, CN

38

Challenge to a portable hemofiltration system in goat

P

H. Sugawara; Chuoshi, JP

39

Modeling of biotechnical system of artificial blood purification with wearable artificial kidney

P

N. Zhilo; Moscow, Zelenograd, RU

40

Trials of wearable artificial kidney SDR-01P

N. Bazaev; Moscow, Zelenograd, RU

41

Risk Factors and Outcomes of Early Peritonitis in Chinese Peritoneal Dialysis Patients

P

Y. Tian; Hangzhou, CN

42

Long-term outcome of patients with rapidly progressive glomerulonephritis requiring dialysis treated with plasmapheresis: a retrospective, single-centre study

P

S. Kaixiang; Hangzhou, CN

43

07.09.2017,Thursday 15:30 16:30-

PS5 Biomaterials - Hydrogels - Scaffolds I

Modification and optimization of polysaccharides for hydrogel formation

P

A. Repanas; Halle (Saale), DE

44

Pegylated hydrogels as a novel drug delivery system against prostate cancer

P

A. Repanas; Halle (Saale), DE

45

Reversible Gelatin Hydrogels based on Semi-Covalent Interactions

P

M. Vahedi; Tehran, IR

46

Mechanical and in-vitro performance of porous hydroxyapatite/poly(lactic acid)/polycaprolactone composite scaffolds

P

H. Ivanković; Zagreb, HR

47

Oxygen permeability measurement of contact lenses: critical points

P

G. D'Avenio; Rome, IT

48

Vibrational spectroscopy of albumin and collagen as materials for creation of biostructures

P

A. Polokhin; Moscow, Zelenograd, RU

49

The Study of Zeta Potential of Gold Nanorods Based on the Electrophoretic Light Scattering Method

P

S. Dolgushin; Zelenograd, Moscow, RU

50

Investigation of the long-term visco-elastic mechanical properties of hernia meshes

P

M. Doneva; Sofia, BG

51

Two scientist, three results - What is the challenge in measuring Magnesium degradation?

P

S. Knigge; Hannover, DE

52

Haemocompatibility assessment of a-C:N:H nitrogen modified, amorphous hydrogenated carbon surface layers on polyether ether ketone

P

M. Gonsior; Zabrze, PL

53

Preparation of atorvastatin calcium loaded PLGA microspheres using solid-in-oil-in-water emulsion method

P

R. Badiani; Tehran, IR

54

Sustained drug delivery of Cyclosporine A (CyA) for extended treatment of dry eye syndrome

P

F. Rafiei; tehran, IR

55

Influence of the degradation process on the release profile of idarubicin for the treatment of glioblastoma multiforme

P

A. Borecka; Sosnowiec, PL

56

07.09.2017,Thursday 15:30 16:30-

PS6 Biomaterials - Hydrogels - Scaffolds II

A conceptual knowledge-based approach to support dental implants planning

P

A. Szejka; Curitiba, BR

57

Requirements to elaborate new design of devices and accessories of ostomy pouching system

P

O. Canciglieri Junior; Curitiba, BR

58

Development for the driving mechanism of implantable artificial tongue

P

T. Yambe; Sendai, JP

59

Magnetically-controlled artificial urinary sphincters.

P

T. Mazzocchi; Pontedera (PI), IT

60

Research of inductive powering unit operation modes

P

E. Mindubaev; Moscow, RU

61

Laser fabrication of nanocarbone scaffolds in protein matrix for reconstruction cartilage and bone tissue

P

A. Gerasimenko; Moscow, RU

62

A new strontium and zinc doped bioglasses for tissue engineering

P

B. Zagrajczuk; Krakow, PL

63

Increasing of mechanical properties of artificial joint ligament by the bionanomaterials laser application method

P

L. Ichkitidze; Moscow, Zelenograd, RU

64

Small, smaller, smallest - A method to produce very small polymeric beads

P

S. Knigge; Hannover, DE

65

Numerical analysis of the PMMA-based cement flow in a trabecular structure of a vertebral

P

K. Sobczak; Lodz, PL

66

Electroactive poly(vinylidene fluoride) membranes with hydrophilic domains for osteogenic differentiation.

P

G. Gallego-Ferrer; Valencia, ES

67

Conducting Biocompatible Nanomaterial Layers

P

L. Ichkitidze; Moscow, Zelenograd, RU

68

07.09.2017,Thursday 15:30 16:30-

PS7 Varia

Superconducting Film Concentrator in Ultraweak Magnetic Field Sensors

P

L. Ichkitidze; Moscow, RU

69

Capacitive-Coupling-based Information Transmission System for Implantable Esophageal pH Monitoring Sensor and Stimulator: Analysis of Receiving Voltage for Electrode Position Modification in Human Anatomical Model

P

Y. Ishioka; Katsushika, JP

70

Possibilities of using combined magnetic field sensors in magnetocardiography

P

L. Ichkitidze; Moscow, Zelenograd, RU

71

Flexible and Implantable Encapsulated Electrode for Measurement of Electrocardiogram

P

K. Lee; Chuncheon, KR

72

In memoriam Alex Medvedev, a career devoted to cardiac assist devices

P

I. Medvedev; Ann Arbor, US

143

07.09.2017,Thursday 15:30 16:30-

PS8 Valves

Methods of tilting disc valves evaluationP

P. Pydziński; Zabrze, PL

73

Polyurethane flexible valve for pulsatile ventricular assist devices

P

M. Gonsior; Zabrze, PL

74

In vitro evaluation of a Styrene-based Polymeric Transcatheter Aortic Valve: The Effect of Leaflet Thickness on Hydrodynamic Function

P

P. De Sciscio; Cambridge, GB

75

In Vitro Modelling of Calcific Particles under Physiological Conditions: A Testbed for Cerebral Protection Devices (CPDs)

P

C. Lierath; Aachen, DE

76

Influence of the bulging sinus size and shape of the stimulated livesize EPTFE valve on the leaflet movement of the valve conduit

P

T. Akutsu; Yokohama, JP

77

07.09.2017,Thursday 15:30 16:30-

PS-L1Late Abstract Poster Session I

Investigation of the axial gap clearance in a hydrodynamic-passive magnetically levitated rotary blood pump using X-ray radiography

PL

B. Thamsen; Zurich, CH

1

CFD study of a pulsatile ventricular assist device operating at high frequency

PL

C. Loosli; Zürich, CH

2

Performance and Efficiency of an Undulating Membrane Based Cardiac Assist Device

PL

P. Monticone; Paris, FR

3

Static and dynamic characterization of four rotary blood pumps

PL

S. Boës; Zurich, CH

4

The Effect of Pulsatility on Haemocompatibility Biomarkers of Rotary Blood Pumps

PL

J. Horobin; Gold Coast, AU

5

Application of soft robotics principles: a soft total artificial heart

PL

N. Cohrs; Zürich, CH

6

Requirements for outpatient care after implantation of a ventricular assist device – view of patients and their relatives

PL

T. Berg; Aachen, DE

7

“I can only sleep with the lights on now” – The different shades of psychological stress after critical illness

PL

A. Chan-Dominy; London, GB

8

07.09.2017,Thursday 16:30 18:00-

A14 Experimental Models for Cardiovascular Devices

16:30 Mock Circulation for Ventricular Assist Devices

O

K. Affeld; Berlin, DE

44

16:45 In vitro flow investigation in the aorta with two different compliances using stereo PIV

O

I. Mueller; Aachen, DE

45

17:00 Optimisation of Numerical Haemolysis Model to Enable Accurate Prediction of Haemolysis Performance in Ventricular Assist Devices

O

A. Molteni; Swansea, GB

46

17:15 The Anastomosis Angle of Outflow Graft to Aorta Influences on Hemodynamics of Aortic Valve Regurgitation in Left Ventricular Assist Device Support

O

K. Iizuka; Osaka, JP

47

17:30 Cardiac Flow Patterns during Mechanical Circulatory Support as a possible Link to Stroke Development

O

P. Aigner; Vienna, AT

48

17:45 Nitric oxide administration to the gas inflow of oxygenator improves cerebral perfusion and neuroprotection during ECMO.

O

N. Ahmed; Verona, IT

49

07.09.2017,Thursday 16:30 18:00-

B14 Challenges for Dialysis Devices

16:30 Haemodialyser clotting: the inner counts.O

F. Vanommeslaeghe; Ghent, BE

50

16:42 Impact of Initial Dialysis Modality on the Survival of Patients with ESRD: a Propensity-Matched Study

O

X. Yao; Hangzhou, CN

51

16:54 Mass-spectrometry based plasma proteomics to find the underlying molecular determinants of hypertension

O

P. Gajjala; Aachen, DE

52

17:06 Blood foam in the air trap during haemodialysis

O

B. Stegmayr; Umea, SE

53

17:18 Differentiation and heterogeneity of biomaterial-induced multinucleated giant cells: connection between inflammation and tissue regeneration

O

M. Barbeck; berlin, DE

54

17:30 Cytokine Profiles In Sepsis PatientsO

T. Eichhorn; Krems, AT

55

17:42 The risk of catheter-related bloodstream infection with temporary femoral hemodialysis catheters

O

V. Gerasimovska; Skopje, MK

56

07.09.2017,Thursday 16:30 18:00-

C14 Symposium: Challenges in Vascular Tissue Engineering

16:30 Vascular Tissue Engineering: "Quo Vadis?"

B. Walpoth; Geneva, CH

16:35 Cell-Assembled Extracellular Matrix (CAM) for Vascular Applications

IL

N. L'Heureux; Bordeaux, FR

16:55 Decellularized human umbilical artery as a potential scaffold for long small diameter tissue engineered vascular grafts

IL

A. Mishanin; St. Petersubrg, RU

17:10 S-Nitroso Human Serum Albumin Releasing Poly(ε-Caprolactone) Small Diameter Vascular Graft

O

M. Enayati; Vienna, AT

57

17:20 Neointima inducing process on small-diameter decellularized vascular graft modified with the bioactive peptide

O

A. Mahara; Osaka, JP

58

17:30 Decellularized small diameter vascular grafts from the human placenta: Assessment of the functional performance in a rat model

O

K. Schneider; Vienna, AT

59

17:40 Application of the xenogeneic decellularized tube matrix produced by in vivo tissue engineering to the 'off-the-shelf' small-caliber vascular graft

O

M. Yamanami; Kyoto, JP

60

17:50 Discussion

07.09.2017,Thursday 16:30 18:00-

D14 Symposium: Numerical Modeling in Hemodialysis

16:30 Effect of double-filtration plasmapheresis for antibody-mediated rejection regarding coagulation parameters and thrombin generation

O

L. Rostaing; Grenoble, FR

124

16:45 Towards longitudinal analysis of arteriovenous fistula for hemodialysis using contrast-free magnetic resonance angiography

O

M. Bozzetto; Ranica (BG), IT

61

16:55 An experimental setup to study the occurrence of perivascular vibrations in arteriovenous vascular access

O

U. Krueger; Berlin, DE

62

17:05 Numerical hemodynamic simulations for monitoring of vascular patients

O

J. Carroll; Sydney, AU

63

17:15 Modelling of cardiovascular alterations during CKD progression

O

G. Casagrande; Milan, IT

64

17:25 Bayesian Identification of Patient-Specific Parameters in a Dialysis Kinetic Model

O

C. Bianchi; Milano, IT

65

17:35 Cardiovascular response to haemodialysis – a new integrated mathematical model

O

L. Pstras; Warsaw, PL

66

17:45 Vascular access in hemodialysis patients: from numerical modeling to vascular biology

IL

A. Remuzzi; Bergamo, IT

08.09.2017,Friday 08:30 09:30-

A21 Heart Regeneration and Transplantation

08:30 Characterization of miRNA expression in cardiac isograft vasculopathy using a heterotopic abdominal mouse heart transplantation model

O

A. Schaefer; Vienna, AT

67

08:42 Remote ischemic postconditioning improves post-ischemic cardiac function:the role of Neuregulin-1

O

P. Pilz; Vienna, AT

68

08:54 A morpho-biomechanical perspective on heart remodeling after MI

O

M. Rusu; Aachen, DE

69

09:06 The OCS HEART system for ex vivo perfusion of the donor heart: A step toward future?

O

l. Botta; Milano, IT

70

09:18 Comparing different unloading strategies in an ovine model of post-infarction heart failure.

O

S. Jacobs; Leuven, BE

71

08.09.2017,Friday 08:30 09:30-

B21 Symposium: Extracellular Vesicles

08:30 Blood purification may interfere with microvesicles in blood

IL

B. Stegmayr; Umea, SE

08:40 Characterization of Extracellular Vesicles in Whole Blood: Influence of Preanalytical Parameters

O

B. Fendl; Krems, AT

72

08:50 Extracellular Vesicles- from Discovery to Clinical Application

IL

A. Reiner; Vienna, AT

09:10 Role of Phosphatidylserine and Tissue Factor in Supporting Extracellular Vesicles Induced Thrombin Generation

IL

C. Tripisciano; Krems, AT

09:20 Discussion

08.09.2017,Friday 08:30 09:30-

C21 Biomaterials II: Soft Tissue Replacement

08:30 The investigation of the influence of the laser solder composition on the welds tensile strength

O

D. Ryabkin; Zelenograd, RU

73

08:40 Investigation of bendability and anisotropy of fiber-based vascular grafts under physiological conditions

O

M. Bode; Hanover, DE

74

08:50 The anticalcification potential of Heparin on hydroxyapatite seed crystals

O

A. Badria; Rion-Patras, GR

75

09:00 The application of poly(L-lactide-co-glycolide-co-trimethylene carbonate) to formulate rods with 17-β-estradiol

O

A. Turek; Sosnowiec, PL

76

09:10 Enhanced Interfacial Bonding Strength of Hydrophobically-modified, Alaska pollock Gelatin-based Surgical Sealants

O

T. Taguchi; Tsukuba, JP

77

09:20 Long-term urine-resistant artificial bladderO

T. Mazzocchi; Pontedera (PI), IT

78

08.09.2017,Friday 08:30 09:30-

D21 Blood Trauma

08:30 Assessment of leukocyte functionality in contact with a foreign surface under shear stress

O

G. Radley; Swansea, GB

79

08:42 Shear stress exposure alters the electrochemical and physical properties of erythrocytes

O

A. McNamee; Gold Coast, AU

80

08:54 Numerical Comparison of Shear and Elongational Stresses in Rotary Ventricular Assist Devices

O

D. Khoo; Bath, GB

81

09:06 Ovine activated leukocyte microparticles generated by the CentriMag ventricular assist device in vitro

O

I. Pieper; Swansea, GB

82

09:18 Evaluation of hemocompatibility of a hydrodynamically levitated centrifugal blood pump using hyperspectral imaging in acute animal studies

O

R. Kosaka; Tsukuba, JP

83

08.09.2017,Friday 09:30 10:00-

PL II Plenary Session II

09:30 The Bionic Hand: Coupling the Brain to Prostheses

PL

O. Aszmann; Vienna, AT

3

10:00 Mechanical Cardiac Support and Cardiac Rhythm Management: A Marriage of two Technologies

PL

M. Hess; Minneapolis, US

4

08.09.2017,Friday 11:00 12:30-

A22 Symposium: Numerical Modelling: Design, Optimization and Functional Characterization of VAD's

11:00 Past and Future of Blood Damage Modelling in Biofluid Mechanics Laboratory

O

L. Goubergrits; Berlin, DE

84

11:12 Strain-Based Blood Damage Modeling – Current Status and Future Perspectives

O

L. Pauli; Aachen, DE

85

11:24 Computational fluid dynamic analyses and in vitro assessment of a novel microfluidic flow-based assay

O

A. Dimasi; Milano, IT

86

11:36 Numerical modeling of the thrombogenic potential of altered hemodynamics at the left ventricular apex-LVAD interface based on non-invasive patient-specific imaging techniques

O

A. Redaelli; Milano, IT

87

11:48 Numerical design improvement and experimental testing of a small VAD

O

K. Fraser; Bath, GB

88

12:00 Influence of pump design variations on hydraulic performance and blood damage: a computational fluid dynamics analysis

O

L. Wiegmann; Zurich, CH

89

12:12 Robust computational tools to improve the development process of mechanical circulatory support

O

T. Kaufmann; Aachen, DE

90

12:24 Summary

08.09.2017,Friday 11:00 12:30-

B22 Emerging Applications in Extracorporeal Therapies

11:00 Lp(a), a risk factor for cardiovascular disease a successful treatment with LDL apheresis

IL

K. Derfler; Vienna, AT

11:30 Extracorporeal therapies in the stem cell transplantation setting

IL

V. Witt; Vienna, AT

11:50 Selective apheresis of C-reactive protein: a new treatment option for myocardial infarction, stroke, pancreatitis, Crohn's disease, after bypass surgery and rheumatic diseases

IL

A. Sheriff; Berlin, DE

12:10 CytoSorb in liver failureIL

B. Tyczynski; Essen, DE

08.09.2017,Friday 11:00 12:30-

C22 Symposium: Nanomedicine

11:00 Two Decades of Commercializing Nanomedicine for Artificial Organs

IL

T. Webster; Boston, US

11:25 3D Printing of Advanced Photopolymers in Tissue Engineering

IL

S. Baudis; Vienna, AT

11:45 Immobilization strategies with glycosaminoglycans-polymeric drug conjugate on biomaterials for anti-inflammatory purposes

O

H. Al-Khoury; Halle (Saale), DE

91

12:00 Electrospinning of fibres for nanomedical applications

O

A. Repanas; Halle (Saale), DE

92

12:15 Vascular grafts with defined fiber orientations

O

C. Grasl; Vienna, AT

93

08.09.2017,Friday 11:00 12:30-

D22 Symposium: Regulatory Affairs

11:00 The new EU Medical Device RegulationIL

J. Vienken; Usingen, DE

11:20 Impact of New European MEDICAL DEVICE REGULATION (MDR) on Artificial Organs Regulatory Approval

O

U. Wallstab; Overath, DE

94

11:32 Clinical evaluation of artificial organs regulated as medical device

O

U. Wallstab; Overath, DE

95

11:44 3D printed medical devices under the perspective of EU regulation

O

M. Grigioni; Rome, IT

96

11:56 Current Status of the Redemption Price of the Medical Devices in Japanese Insurance System during 2015-2016

O

E. Akagawa; Suita, JP

97

12:08 Nanostructured medical devices: the need for a specific roadmap of the regulatory framework

O

M. Grigioni; Rome, IT

98

12:20 Discussion

08.09.2017,Friday 12:30 13:30-

LS II Lunch with Plenary Lecture 5

12:30 Dialysis: From an Awkward, Complicated Method to a Mass Therapy and Beyond

PL

E. Leonard; New York, US

5

08.09.2017,Friday 13:30 15:30-

A23 Symposium: Blood Damage in Rotary Assist Devices

13:30 Blood trauma in rotary blood pumps, an introduction

U. Kertzscher; Berlin, DE

13:35 Advanced Surface Properties to Mitigate Hemolysis and Thrombosis

IL

M. Kameneva; Pittsburgh, US

13:50 Visualized erythrocyte’s shear induced damage process under high shear flow

O

N. Watanabe; Saitama-City, JP

99

14:02 Red blood cell responses to shear stress exposure in patients un/likely to receive mechanical circulatory support

O

M. Simmonds; Gold Coast, AU

100

14:14 Investigation of Shear-Induced Platelet Damage with a Couette Shear Device

O

M. Lommel; Berlin, DE

101

14:26 Von Willebrand Factor and a Correlation to Turbulence

O

K. Affeld; Berlin, DE

102

14:38 Can we predict the thrombotic risk in patients with Left Ventricular Assist Devices?

O

F. Consolo; Milano, IT

103

14:50 Influence of dynamically changing operating conditions on the hemocompatibilty of rotary blood pumps

O

B. Thamsen; Zurich, CH

104

15:02 A modified Chandler-Loop as a benchmark for hemodynamic simulation studies.

O

S. Engel; Hannover, DE

105

15:14 Panel Discussion

08.09.2017,Friday 13:30 15:30-

B23 Symposium: Dialysis of Today and Tomorrow

13:30 Introduction: Different survival on dialysis in USA, Europe and Japan

B. Stegmayr; Umea, SE

13:35 Japanese strategies of dialysis today and tomorrow

IL

K. Matsuda; Tokyo, JP

14:00 Carbon Block Column (CB) for Regeneration of Dialysate in CVVHD

O

S. Ash; Lafayette, Indiana, US

106

14:25 Large uremic toxins: clinical relevance and strategies for remova

IL

S. Eloot; Ghent, BE

14:37 Release of uremic retention solutes from protein binding by hypertonic predilution hemodiafiltration

IL

J. Jankowski; Aachen, DE

14:49 (Bio)artificial kidney systems for improved blood purification

IL

D. Stamatialis; Twente, NL

15:01 Peritoneal dialysis for urgent dialysis initiation

IL

B. Lindholm; Stockholm, SE

15:13 Discussion

08.09.2017,Friday 13:30 15:00-

C23 Tissue Engineering & Regenerative Medicine II

13:30 TERM in the Austrian Cluster for Tissue Regeneration

IL

H. Redl; Vienna, AT

14:00 An influence of the zinc oxide nanoparticles on properties of the endothelial cells cultured under physiological flow

O

A. Ciechanowska; Warsaw, PL

107

14:12 Material-driven assembly of fibronectin (nano)networks in 2D substrates and 3D scaffolds: effect of chemical crosslinking on fibronectin organization

O

R. Sabater i Serra; València, ES

108

14:24 Microspheroid Assemblies : Levitating PCL –IO Spheroids in Biomaterial Applications – Insights from Respirometry

O

F. Fernandez; Trivandrum, IN

109

14:36 Human induced pluripotent stem cells-based strategies for bone tissue engineering and regeneration.

O

D. Marolt Presen; Vienna, AT

110

14:48 Osteogenic differentiation of human mesenchymal stem cells under physiological fluid shear stress

O

C. Kasper; Vienna, AT

111

08.09.2017,Friday 13:30 15:30-

D23 Symposium: Artificial Lung

13:30 tbaIL

M. Quintel; Göttingen, DE

14:00 Intracorporeal Membrane Catheter for CO2 Reduction in the Blood – Membrane Contactor

O

M. Harasek; Vienna, AT

112

14:15 In Vitro Characterization of the Pittsburgh Pediatric Ambulatory Lung Device

O

R. Orizondo; Pittsburgh, US

113

14:30 RAS-Q – A Novel Passive Right Heart Assist System

O

T. Kaufmann; Aachen, DE

114

14:45 Controlled Blood Recirculation Enhances Oxygenation Efficiency in an Artificial Lung

O

S. P. Madhani; Pittsburgh, US

115

15:00 Investigations of Thrombus Distribution After Long Term ECMO and Blood Flow Distribution Using CFD in An Oxygenator

O

N. KATAGIRI; Suita, Osaka, JP

116

15:15 In-Vitro and In-Vivo Studies of an Integrated, Wearable Blood Pump-Lung

O

S. Madhani; Pittsburgh, US

117

08.09.2017,Friday 15:30 16:30-

PS9 Pump Development

Long-term use Assessment of the Apico-Aortic Blood Pump: Durability and wear assessment

P

B. Utiyama; Sao Paulo, BR

78

Transventricular Assist Device (TVAD) – In Vitro evaluation of a new axial blood pump using polymeric valve for rotational speed reduction

P

A. Andrade; Sao Paulo, BR

79

Precision matching pulsatile blood pumpP

M. Yang; Shaghai, CN

80

Total artificial heart (TAH): preliminary results in vitro

P

D. Galantini; São Paulo, BR

81

Methodology for the Application of Risk Analysis to Improve the Reliability of Ventricular Assit Device

P

J. Dias; São Paulo, BR

82

Remote Monitoring of Russian VAD system AVK-N

P

G. Itkin; Moscow, RU

83

Tele-care and tele-rehabilitation model for VAD patient’s treatment

P

R. Kustosz; Zabrze, PL

84

Integration of Ultrasonic Flow Measurement in Cardiac Support Systems

P

E. Huber; Finning, DE

85

Design of a Smart System for a Ventricular Assist Device

P

M. Barboza; São Paulo, BR

86

Preliminary results of In Vitro endothelialization on plasma modified titanium surface

P

E. Drigo; São Paulo, BR

87

Design optimization and in vitro and in vivo verification of CorWave disk membrane LVAD

P

P. Monticone; Paris, FR

88

08.09.2017,Friday 15:30 16:30-

PS10 Experimental and Numerical Modelling

In-vitro Measurement of Centering Forces on a Transvalvular Ventricular Assist Device Cannula

P

M. Stoiber; Vienna, AT

89

Blood viscosity investigation to define best numerical and in vitro test values to benchmark VAD performance

P

C. Moriarty; Swansea, GB

90

Quantitative assessment of heart-pump interaction for an axial-flow rotary blood pump Sputnik: in vitro study

P

D. Petukhov; Zelenograd, RU

91

Development of Frank-Starling mechanical mock circulatory loop for rotary blood pump testing

P

T. Khienwad; Nakhon Pathom, TH

92

Modelling the impact of hypertension on continuous flow left ventricular assist device function

P

C. Hayward; Sydney, AU

93

Computerized closed-loop propofol anaesthesia in cardiac surgery.

P

V. Magilevets; Moscow, RU

94

Virtual patient in studies of ventilation capacity improvement by LVAD support in congestive heart failure

P

K. Zielinski; Warsaw, PL

95

Fluid dynamical study of the univentricular patient: the case of HLHS

P

G. D'Avenio; Rome, IT

96

Minimal model of cardiovascular system assisted by a veno-arterial extracorporeal membrane oxygenation

P

S. Habran; Liege, BE

97

Evaluation of a hybrid cardiovascular simulator

P

J. Fonseca; Sao Paulo, BR

98

Measurements of pressure drop in arteriovenous fistula models - in vitro investigations

P

D. Jodko; Lodz, PL

99

Numerical Simulation of the HeartMate 3P

M. Nicolai; Berlin, DE

100

Can Simulation Become a Preoperative Planning Approach in Patients Requiring Mechanical Circulatory Support?

P

M. Capoccia; Leicester, GB

101

08.09.2017,Friday 15:30 16:30-

PS11 Artificial Lung and Respiratory Support

Effects of Hollow Fiber Oscillation on Artificial Lungs

P

R. Orizondo; Pittsburgh, US

102

Multiobjective Design Optimization of Endothelializable Oxygenator Membranes Using Computational Fluid Dynamics

P

F. Hesselmann; Aachen, DE

103

Experimental Flow Visualization and Wall Shear Stress Measurements in an Endothelializable Membrane Oxygenator Using Particle Tracking Velocimetry

P

F. Hesselmann; Aachen, DE

104

Oxygen Mass Transfer in a Surrogate System of Membrane Blood Oxygenators

P

C. Moreira; Lisbon, PT

105

Intracorporeal Membrane Catheter for CO2 Reduction in the Blood – Drive Unit and Control System

P

M. Gföhler; Vienna, AT

106

The use of an artificial patient in analysis of possible causes of changes in arterial blood gases during therapeutic thoracentesis

P

A. Stecka; Warsaw, PL

107

In-vivo study of a novel lung support device for PAH and bridge-to-transplant/candidacy

P

T. Verbelen; Aachen, DE

108

08.09.2017,Friday 15:30 16:30-

PS12 Dialysis/Apheresis - Clinical

Therapeutic apheresis in severe Guillain-Barre syndrome – our experience from 2009 to 2017

P

A. Marn Pernat; Ljubljana, SI

109

Immunology Absorption induces remission in ANCA-associated vasculitis

P

X. Lei; Hangzhou, CN

110

Changes of subjective global assessment is associated with clinical outcomes of peritoneal dialysis patients

P

X. Yan; Hangzhou, CN

111

Relationship between serum uric acid and all-cause mortality in maintenance hemodialysis patients

P

L. Zhang; Hangzhou, CN

112

Association between medical insurance type and survival in hemodialysis patients in China

P

X. Yao; Hangzhou, CN

113

Epidemiological Survey of Incident End Stage Renal Disease Patients from 2010 to 2014 in Zhejiang Province, China

P

W. Lei; Hangzhou, CN

114

Genome-wide analysis of DNA methylation and gene expression characteristics of dialysate-induced peritoneal fibrosis

P

P. Yan; Hangzhou, CN

115

Tamoxifen attenuates PDF-induced peritoneal fibrosis via reducing GSK3β/β-catenin axis activation

P

P. Yan; Hangzhou, CN

116

08.09.2017,Friday 15:30 16:30-

PS13 Tissue Engineering and Organ Regeneration I

An in vitro skin wound infection model and bioevaluation of antimicrobial wound dressings

P

A. Idrees; Bochum, DE

117

Development of Tissue-Engineered Cardiac Patch based on Silk Fibroin

P

Y. Nakazawa; Tokyo, JP

118

Microparticles from decellularized human liver tissue for increasing the biocompatibility of artificial grafts

P

M. Bobrova; Moscow, RU

119

Tissue engineering as a way for working out a bioartificial liver support at the treatment of chronic liver failure

P

M. Shagidulin; Moscow, RU

120

Preparation of Decellularized Porcine Renal Scaffolds for Potential Xenotransplantation: Technique and

P

K. Hussein; Chuncheon, KR

121

Extract of cryopreserved piglets heart fragments as regulating agent proceeding of experimental myocardial necrosis

P

L. Rohoza; Kharkiv, UA

122

Characterization of the functionalized biodegradable collagen scaffolds for in vivo delivery of SDF-1α and substances with bactericidal activity

P

I. Pokholenko; Kyiv, UA

123

Genetically modified human hepatoma and feeder layer cells for bioartificial liver devices

P

A. Samluk; Warsaw, PL

124

08.09.2017,Friday 15:30 16:30-

PS14 Tissue Engineering and Organ Regeneration II

Development of an in-situ transfection system for regeneration of bone

P

Y. Brito Barrera; Halle (Saale), DE

125

Studies on osteogenic differentiation of cells on multilayers loaded with BMP-2

P

R. Anouz; Halle (Saale), DE

126

Effect of pO2 on viability and staging of bovine follicles cultured in vitro in dishes in strips of ovarian cortical tissue

P

G. Catapano; Rende, IT

127

Mathematical modeling and experimental procedures for tissue engineering of blood vessels by electrospinning

P

N. Filipovic; Kragujevac, RS

128

A Datamining Approach for Anatomic Skull Prosthesis Modelling Optimization

P

O. Canciglieri Junior; Curitiba, BR

129

Effect of non-uniform construct permeability on matter distribution in radial flow packed bed bioreactors (rPBBs) for bone tissue engineering (BTE)

P

G. Falvo D'Urso Labate; Rende, IT

130

Non-contact Measurement of Dielectric Properties of Biological Tissues using Magnetic Induction at 500 kHz

P

S. Kawai; katsushika, JP

131

Controlled infiltration of cells into electrospun scaffolds fabricated for application in small diameter vascular grafts

P

S. Suresh; Hannover, DE

132

08.09.2017,Friday 15:30 16:30-

PS15 Tissue Engineering and Regenerative Medicine

Poly(L-lactic acid) microspheres induce “in vivo” articular cartilage regeneration in rabbits

P

M. Sancho-Tello; Valencia, ES

133

Silk fibroin/collagen films for rat skin wound regeneration

P

L. Safonova; Moscow, RU

134

3D porous polycaprolactone scaffolds for cartilage regeneration

P

M. Sancho-Tello Valls; Valencia, ES

135

Force induced piezoelectric effect of PVDF and PVDF-TrFE scaffolds

P

F. AL Halabi; Hannover, DE

136

Poly(L-lactic acid) (PLLA) mats for human airway mucosa regeneration

P

M. Sancho-Tello Valls; Valencia, ES

137

Does excess gravity affect cell deformation and orientation after stimulation?

P

S. Hashimoto; Tokyo, JP

138

Measurement of Contraction of Myotube on Scaffold Film with Micro-markers by Electric Stimulation

P

S. Hashimoto; Tokyo, JP

139

Effect of the co-application of Matriderm and mesenchymal stem cells on wound healing

P

I. Lang; Graz, AT

140

Spheroid-based 3D culture model with PC12 cells for application of neuronal stimulation electrodes

P

S. Lee; Cheonju-si, Chungbuk, KR

141

Myoblast migrates under controlled wall shear stress field in vitro

P

S. Hashimoto; Tokyo, JP

142

08.09.2017,Friday 15:30 16:30-

PS-L2Late Abstract Poster Session II

In Vitro Testing of an Integrated, Low Flow Extracorporeal CO2 Removal Device

PL

A. May; Pittsburgh, US

9

Application of oxygen micro/nano bubble dispersions for total liquid ventilation

PL

H. Sato; Shinjuku, JP

10

A capillary membrane oxygenator with integrated pump function for organ transplant perfusion.

PL

F. Mouzakis; Aachen, DE

11

Removal capability of CytoSorb hemadsorption columns for selected drugs frequently used for deliberate drug overdose

PL

A. Koertge; Rostock, DE

12

In Vitro Investigations of Membrane Permeabilities of Various Hemofilters

PL

T. Wild; Rostock, DE

13

A single venesection improves the mechanical properties of blood in patients with haemochromatosis

PL

K. Richardson; Gold Coast, AU

14

Effect of venous stenosis on flow resistance: A fluid dynamic model

PL

F. Mouzakis; Aachen, DE

15

Tissue-engineered skeletal muscle and its application to actuator with long-term drivability

PL

T. Fujisato; Osaka, JP

16

08.09.2017,Friday 16:30 18:00-

A24 Computational Fluid Dynamics I

16:30 Evaluation of Numerical Models in Simulation of Intraventricular Flow Pattern with Left Ventricular Assist Device Support

O

M. Ghodrati; Vienna, AT

118

16:45 The effect of inflow cannula insertion lengths on the risk of ventricular thrombosis in a multiscale numerical model

O

S. Liao; Chermside, AU

119

17:00 Comparison of an Unsteady-Reynolds-Averaged and a Very-Large-Eddy Simulation regarding their Potential to Predict Hemolysis with Stress-Based Hemolysis Models

O

L. Konnigk; Rostock, DE

120

17:15 Numerical modelling of leukocyte deformation in Ventricular Assist Devices

O

K. Fraser; Bath, GB

121

17:30 An extensive comparison of power-law-based hemolysis models for the blood pump of the FDA’s Critical path challenge.

O

S. Engel; Magdeburg, DE

122

17:45 Development of Prediction Methods of Shear induced Thrombus Formation by CFD Method including Concentration Transport and Aggregation Process and by Thrombus Visualization Method

O

M. Tamagawa; Kitakyushu, JP

123

08.09.2017,Friday 16:30 18:00-

B24 Transplantation Related Aspects of Dialysis

16:30 Apheresis in Renal TransplantationIL

G. Böhmig; Vienna, AT

16:55 tba

17:10 Efficacy and Safety of Cinacalcet Therapy for Renal Transplant Patients with Secondary Hyperparathyroidism—A Systematic Review and Meta-Analysis

O

Y. Lu; Hangzhou, CN

125

17:25 Tacrolimus Dose Requirement Based on the CYP3A5 Genotype in Renal Transplant Patients

O

L. Qu; Hangzhou, CN

126

17:40 Discussion

08.09.2017,Friday 16:30 18:00-

C24 "Bioartificial Organs" Working Group

16:30 Novel membrane systems for pancreatic cell encapsulation

IL

D. Stamatialis; Twente, NL

16:50 Advances in cell microencapsulation for bioartificial liver

IL

C. Legallais; Compiegne, FR

17:05 Can we bioengineer functional kidney tissue?

IL

R. Masereeuw; Utrecht, NL

17:20 Achievements and hurdles of kidney bioengineering

IL

A. Remuzzi; Bergamo, IT

17:35 Engineering blood and lymphatic vascular beds

IL

W. Holnthoner; Vienna, AT

17:50 Discussion

08.09.2017,Friday 16:30 18:00-

D24 Clinical Reports and Exercise

16:30 Acute and Long-term effects of LVAD support on right ventricular function in children with pediatric pulsatile ventricular assist devices

O

R. Iacobelli; Rome, IT

127

16:45 Short and Long Term Changes in Ventricular Loading Condition in LVAD patients: pulsatile vs continuous flow LVAD

O

A. Di Molfetta; Rome, IT

128

17:00 Do LVADs provide sufficient cardiac support during physical exercise when driven at constant speed?

O

C. Gross; Vienna, AT

129

17:15 Exercise capacity in VAD and heart transplanted patients: a comparative study

O

L. Fresiello; Leuven, BE

130

17:30 The Clinical Results, Adverse Events, and Change of End-organ Function in Elderly Patients with HeartMateII LVAD ~Japanese Multicenter Study~

O

D. Yoshioka; Suita, JP

131

17:45 Viennese experience with the HeartMate III Left Ventricular Assist Device

O

K. Dimitrov; Vienna, AT

132

08.09.2017,Friday 18:00 19:00-

GA ESAO General Assembly

18:00 only for members

09.09.2017,Saturday 08:30 09:30-

A31 Computational Fluid Dynamics II

08:30 Fluid-Structure Interaction (FSI) Hemodynamic Optimization of CorWave Endovascular Cardiac Assist Device

O

F. Cornat; Paris, FR

133

08:40 Rotordynamic analysis of an artificial axial-flow cardiac-pump using Bond-graph methodology

O

J. Kumar; Rostock, DE

134

08:50 A novel generic model for the investigation of intraventricular flow patterns in individual hearts

O

K. Hugenroth; Aachen, DE

135

09:00 CFD modeling of IABP-induced abdominal occlusions and statistical analysis of effects on hemodynamics

O

G. Fragomeni; Catanzaro, IT

136

09:10 Effect of inflow cannulas side-hole number on drainage flow characteristics: flow dynamic analysis using numerical simulation

O

T. Goto; HIrosaki, JP

137

09:20 Modeling Maturation of Patient-Specific Arteriovenous Fistula's Using Computational Fluid Dynamics

O

E. Colley; Sydney, AU

138

09.09.2017,Saturday 08:30 09:30-

B31 Uremic Toxins I: EUTOX Symposium

08:30 Intra-dialyser Transmembrane and Hydrostatic pressures and convection: Measurement pitfalls and relevance

IL

À. Argilés; Montpellier, FR

08:50 Bubbling the extra-corporeal circuits: where the bubbles come from, are they harmful and can we prevent their appearance?

IL

B. Stegmayr; Umea, SE

09:10 Protein – bound toxins: Increased release results in increased removal

IL

J. Jankowski; Aachen, DE

09.09.2017,Saturday 08:30 09:30-

C31 Tissue Engineering & Regenerative Medicine III

08:30 Fabrication of Proanthocyanidin cross-linked Chitosan-Gelatin hydrogel scaffolds for tissue engineering

O

A. Encerrado Flores; Nottingham, GB

139

08:42 Fabrication of porous poly(trimethylene carbonate) membranes for lungs-on-chips

O

T. Pasman; Enschede, NL

140

08:54 Rapamycin Inhibits Epithelial-to-Mesenchymal Transition of Peritoneal Mesothelium Cells through Regulation of RhoGTPases

O

X. Shilong; Hang Zhou,Zhe Jiang, CN

141

09:06 Decellularized Liver Extracellular Matrix Gel Promotes Resolution of Liver Fibrosis in Mice

O

K. Hussein; Chuncheon, KR

142

09:18 Towards a fully implantable autonomous artificial pancreas

O

V. Iacovacci; Pontedera, IT

143

09.09.2017,Saturday 08:30 09:30-

D31 Symposium: 3D Additive Manufacturing / Biofabrication

08:30 Nanostructuring and nanoscopy in 3DIL

J. Jacak; Linz, AT

08:45 Application of indirect optical micromanipulation in fluorescent, 3D live cell imaging

IL

L. Kelemen; Szeged, HU

09:00 Generation of photo-induced microstructures on biomaterial surfaces for control of cell attachment.

IL

J. Heitz; Linz, AT

09:15 Open-source 3D biofabrication platform for specialized scientific and industrial solutions

IL

B. Vihar; Maribor, SI

09.09.2017,Saturday 09:30 10:30-

PL III Plenary Session III

Apheresis for Dilated CardiomyopathyPL

J. Winters; Rochester, US

6

09:30 Medical device innovation in Asia and Japan - Present and future strategy

PL

Y. Taenaka; Osaka, JP

7

09.09.2017,Saturday 11:00 12:30-

A32 Symposium: Challenges in Tailoring a Rehabilitation Program

11:00 How to set up a rehabilitation program for patients with left ventricular assist device

IL

N. Reiss; Bad Rothenfelde, DE

11:15 tbdIL

11:30 Can rehabilitation prevent LVAD related complications?

IL

C. Hayward; Sydney, AU

11:45 Hot topics in the long term psycho-social care

IL

C. Kugler; Freiburg, DE

12:00 Panel Discussion

09.09.2017,Saturday 11:00 12:30-

B32 Uremic Toxins II

11:00 Exploring protein binding of different uraemic toxins

O

O. Deltombe; Ghent, BE

144

11:12 Modelling uremic toxicity: further steps towards a precise in vitro detection of toxic effects caused by uremic retention solutes

O

T. Vollmer; Berlin, DE

145

11:24 Not creatinine but protein-bound uraemic toxins are predominant in the prediction of QoL in children with CKD

O

E. Snauwaert; Ghent, BE

146

11:36 Alkaline phosphatase and combined alkaline phosphatase and iPTH influences clinical outcome in peritoneal dialysis patients

O

Z. Chen; Hangzhou, CN

147

11:48 Clinical investigation of 120 peritoneal dialysis patients combined with extraosseous calcification

O

S. Wang; Hangzhou, CN

148

12:00 Numerical modelling of microcirculation fluid exchanges in uremic patients accounting for the non-linear effect of lymphatic system

O

L. Possenti; Milan, IT

149

12:12 Which Uremic Toxins are Affecting Vascular Calcification?

O

J. Holmar; Aachen, DE

150

12:24 Discussion

09.09.2017,Saturday 11:00 12:30-

C32 Tissue Engineering & Regenerative Medicine IV

11:00 Strategies for the expansion and differentiation of human mesenchymal stem cells under physiological conditions

O

C. Kasper; Vienna, AT

151

11:20 3D oxygen transport model in strips of ovarian cortical tissue: a basic tool for assisted reproduction techniques

O

G. Falvo D'Urso Labate; Rende, IT

152

11:32 Fiber size and composition as tools to manipulate wettability and compliance of electrospun tubular scaffolds to enhance tissue regeneration.

O

M. Mueller; Hannover, DE

153

11:44 Laser engraving promotes the repopulation of decellularized articular cartilage

O

S. Nürnberger; Vienna, AT

154

11:56 Regeneration and Osteointegration of the Anterior Cruciate Ligament using a Novel Silk Fiber based Scaffold

O

T. Nau; Vienna, AT

155

12:08 Development of Injectable Cell Scaffold for Cell Therapy

O

T. Furuzono; Kinokawa, Wakayama, JP

156

12:20 Discussion

09.09.2017,Saturday 11:00 12:30-

D32 Ventricular Assist Devices: The next Generation

11:00 Relationship between fluid force fluctuation and impeller design for magnetically levitated centrifugal blood pumps

O

T. Masuzawa; Hitachi, JP

157

11:15 Development of a hydrodynamically levitated centrifugal blood pump for long-term extracorporeal mechanical circulatory support systems

O

T. Tsukiya; Suita, JP

158

11:30 A Novel, Miniaturized VAD Configured for Right-Heart MCS

O

J. Stanfield; Salt Lake City, US

159

11:45 Novel Pediatric Axial Rotary Blood PumpO

D. Telyshev; Moscow, RU

160

12:00 Development of a Miniature, Hemocompatible Continuous Flow Pediatric Ventricular Assist Device

O

J. Stanfield; Salt Lake City, US

161

12:15 Next generation ultracompact centrifugal pediatric VAD with full axis controlled maglev motor

O

M. Osa; Hitachi, JP

162

09.09.2017,Saturday 12:30 13:00-

CC Closing Ceremony

12:30 Closing Remarks: ESAO President

C. Legallais; Compiegne, FR

12:35 Closing Remarks: IFAO President

B. Stegmayr; Umea, SE

12:40 Presentation of the ESAO Innovation Award and the ESAO Poster Awards

12:50 Announcement of the next ESAO Congress

J. Canizo; Madrid, ES

12:55 Announcement of the next IFAO Congress

13:00 Farewell Lunch